Next Article in Journal
The Effect of Mental Fatigue on Cognitive and Aerobic Performance in Adolescent Active Endurance Athletes: Insights from a Randomized Counterbalanced, Cross-Over Trial
Previous Article in Journal
Clinical Impact of Sequence Type 131 in Adults with Community-Onset Monomicrobial Escherichia Coli Bacteremia
 
 
Search for Articles:
Title / Keyword
Author / Affiliation / Email
Journal
Article Type
 
 
Advanced Search
 
Section
Special Issue
Volume
Issue
Number
Page
 
Journals
JCM
Volume 7
Issue 12
10.3390/jcm7120509
jcm-logo
Submit to this Journal Review for this Journal Propose a Special Issue
► Article Menu

Article Menu

share Share announcement Help format_quote Cite question_answer Discuss in SciProfiles thumb_up
...
Endorse textsms
...
Comment
first_page
settings
Order Article Reprints
Font Type:
Arial Georgia Verdana
Font Size:
Aa Aa Aa
Line Spacing:
Column Width:
Background:
Article

Evolution of ST-Elevation Acute Myocardial Infarction Prevalence by Gender Assessed Age Pyramid Analysis—The Piramyd Study

by
Aurélie Loyeau
1,
Hakim Benamer
2,3,
Sophie Bataille
1,
Sarah Tepper
4,5,
Thévy Boche
6,
Lionel Lamhaut
6,7,8,9,
Virginie Pirès
10,
Benoit Simon
11,
François Dupas
12,
Lisa Weisslinger
4,5,
Gaëlle Le Bail
13,
Alexandre Allonneau
14,
Jean-Michel Juliard
15,
Yves Lambert
16 and
Frédéric Lapostolle
4,5,*
1
Registry Department, Regional Health Agency in Great Paris Area, 75008 Paris, France
2
Ramsay Générale de Santé, ICPS, 6 Avenue du Noyer Lambert à Massy, 91300 Massy, France
3
Service de cardiologie Hôpital Européen de Paris—La Roseraie, 93300 Aubervilliers, France
4
SAMU 93, UF Recherche-Enseignement-Qualité Avicenne Hospital-APHP, 93000 Bobigny, France
5
Université Paris 13, Sorbonne Paris Cité, 75008 Paris, France
6
SAMU 94 Mondor Hospital-APHP, 94000 Créteil, France
7
SAMU de Paris – DAR, Necker Hospital-APHP, 75008 Paris, France
8
Université Paris Descartes, 75008 Paris, France
9
INSERM U 970 équipe 4, 75008 Paris, France
10
SAMU 77, Melun Hospital, 77000 Melun, France
11
SAMU 91, Sud Francilien Hospital, 91100 Corbeil-Essonnes, France
12
SAMU 95, Pontoise Hospital, 95032 Pontoise, France
13
SAMU 92, Garches Hospital-APHP, 92380 Garches, France
14
Fire Departement of Paris, EMS Department, 75008 Paris, France
15
Cardiology Department, DHU FIRE, Université Paris Diderot, Sorbonne Paris-Cité, INSERM U-1148, Bichat Hospital-APHP, 75008 Paris, France
16
SAMU 78, Versailles Hospital, 78150 Le Chesnay, France
 
add Show full affiliation list
 
remove Hide full affiliation list
*
Author to whom correspondence should be addressed.
J. Clin. Med. 2018, 7(12), 509; https://doi.org/10.3390/jcm7120509
Submission received: 19 October 2018 / Revised: 12 November 2018 / Accepted: 23 November 2018 / Published: 3 December 2018
(This article belongs to the Section Cardiology)
Browse Figures
Review Reports Versions Notes

Abstract

:
Introduction: Recent studies reported a decrease in the incidence of acute myocardial infarction. This favorable evolution does not extend to young women. The interaction between gender, risk factors and myocardial infarction incidence remains controversial. Objective: To compare the evolution of the age pyramid of patients with ST-elevation myocardial infarction (STEMI) according to gender. Methods: Data from patients with STEMI managed in pre-hospital settings prospectively collected in the greater Paris area. Evolution of patient demographics and risk factors was investigated. Results: 28,249 patients with STEMI were included in the registry between 2002 and 2014, 21,883 (77%) males and 6366 (23%) females. The sex ratio did not significantly vary over the study period (p = 0.4). Median patient age was 60.1 years (51.1–73.0) and was significantly different between males and females, respectively 57.9 (50.0–68.3) vs. 72.9 years (58.3–82.2) (p = 0.0004). The median age of males significantly (p = 0.0044) increased from 57.6 (50.1–70.0) in 2002 to 58.1 years (50.5–67.8) in 2014. The median age of females significantly (p = 0.0006) decreased from 73.7 (57.9–81.8) to 69.6 years (57.0–82.4). The median gap between the age of men and women significantly (p = 0.0002) decreased, from 16.1 to 11.5 years. Prevalence of risk factors was unchanged or decreased except for hypertension which significantly increased in males. The rate of STEMI without reported risk factors increased in both males and females. Conclusion: The age of STEMI onset significantly decreased in females, whereas it significantly increased in males. The prevalence of risk factors decreased in males, whereas no significant variation was found in females.

1. Introduction

Many studies have reported a decrease in the incidence of ST-segment elevation acute myocardial infarction (STEMI) in recent years in Europe and in the United States [1,2]. This finding contrasts with the overall increase in the prevalence of cardiovascular risk factors, particularly diabetes, cholesterol and obesity, and even smoking [3,4,5,6]. However, this trend seems to involve almost all Western countries, all age groups and both genders. Nevertheless, it would appear that this favorable evolution does not extend to young women [7]. The prevalence of risk factors, particularly smoking, is suspected to account for this evolution. This could be particularly true in France where the prevalence of smoking has increased dramatically in women over the last decade, having even doubled in those aged 55–64 [8]. This is important, because smoking is the main determining factor of cardiovascular risk in many young people. Thus, in patients under 55 years of age who had an acute myocardial infarction, smoking was the sole cardiovascular risk factor in 80% of cases [9]. The interaction between risk factors and gender is certainly crucial, but difficult to substantiate. Furthermore, it seemed to us that the analysis of the age pyramid in a registry of acute myocardial infarction that had been running since 2002 would make it possible to study the evolution of the age of onset of acute myocardial infarction.

2. Methods

2.1. Settings

In France, patients experiencing acute chest pain are urged to rapidly contact the emergency medical services using a nationwide telephone number (15). The medical dispatch centers (SAMUs) which take these calls are uniformly organized in all regional districts and are run by emergency physicians. In cases of suspected acute coronary syndrome, the physician can dispatch a mobile intensive care unit (MICU) manned by an ambulance driver, a nurse trained in emergency medicine, an emergency physician, and in most instances a student. Emergency diagnostic and therapeutic facilities are available on board the MICU, including electrocardiograph (ECG), laboratory test facilities (including troponin assays), ultrasound and drugs (including fibrinolytic agents, antiplatelet agents, anticoagulation, etc.). The decision to perform myocardial reperfusion and the choice of the technique (i.e., prehospital fibrinolysis or primary percutaneous coronary intervention, PCI) are made by the onsite physician in coordination with the medical dispatch center physician and the cardiologist in the unit to which the patient will be admitted. SAMU and MICU are also responsible for the transfer of STEMI patients from hospitals without PCI facilities to cath-labs.
The Greater Paris area includes the city of Paris, three inner suburbs (regional districts) and four outer suburbs. The total area covers a surface of 12,012 km2 with a total population of 12 million inhabitants. Each district has its own medical dispatch center (8 SAMUs in total) operating a total of 40 MICUs. Patients are taken to 36 cardiology units with 24/24 PCI facilities.

2.2. E-MUST Registry

The e-Must registry contains prospectively collected data on acute myocardial infarction patients handled in prehospital settings by the SAMU of the Greater Paris area. All patients with chest pain lasting less than 24 h, ECG signs of STEMI, and managed by one of the 40 MICU teams are prospectively included in the registry regardless of the severity of the STEMI, and of any administered treatments, including reperfusion strategy (prehospital fibrinolysis or primary PCI) and prehospital and in-hospital outcomes.
Data collected are as follow: patient demographics (age and gender), risk factors, STEMI conditions (infarction location and clinical severity criteria), administered drugs (and time of administration), chosen reperfusion strategy (fibrinolysis or primary PCI) and in-hospital outcome. All the time intervals (chest pain onset/call to the SAMU/first medical contact/treatment/hospital arrival/puncture/balloon) are recorded. Recorded risk factors are: personal coronary history, coronary artery disease in the family, smoking, diabetes, hypertension, dyslipidemia, overweight. Risk factors were identified based on ongoing treatment, drug prescription, previous consultation or hospitalization and self-reported by patient questionnaire. Their definition did not change during the study period. Risk factors have only been included in the registry since 2006.
All patients are informed of their inclusion in the registry which has been registered with the French Data Protection Agency (CNIL—Commission nationale de l’informatique et des libertés) and they receive both oral and written information. The physician in charge of the patient in the prehospital setting checks all data before entry into the registry and carries out a monthly audit. An annual regional audit is conducted under the auspices of the Regional Health Agency (ARS—Agence Régionale de Santé) which posts the results for the region, and for each SAMU and MICU on a dedicated website (http://www.cardio-arsif.org).

2.3. Study Design, Data Extraction and Statistical Analysis

This was an observational study based on data extracted from the e-MUST registry for the period 2002–2014. The following data were extracted for analysis: Patient demographics and risk factors.
The evolution of the median age of both male and female populations and the prevalence of risk factors during the period were studied by calculating the correlation coefficient (r) and using the Cochran-Armitage trend test. An r value between 0.6 and 0.79 was considered indicative of a strong, downhill or uphill, linear correlation and an r value between 0.8 and 1 indicative of a very strong correlation [10].
The evolution of the age pyramid for male and female populations was evaluated by using the Kolmogorov-Smirnov test. Percentages are used to describe categorical variables and median and inter-quartiles to describes continuous variables. All tests were 2-tailed with the level of statistical significance prespecified at 5% (p < 0.05). Statistical analyses were performed using SAS® Software 9.4 (Cary, CA, USA).

3. Results

A total of 28,411 patients managed in pre-hospital settings for STEMI were included in the registry between 2002 and 2014. One hundred sixty-two (0.5%) patients were excluded because age (n = 93) or gender (n = 69) were missing (Figure 1). The median number of patients included was 2168 (2063–2205) per year without significant change during the study period.
Overall, 28,249 patients were included in the analysis, of whom 21,883 (77%) were men and 6366 (23%) women. The median number of patients included was 2168 (2063–2205) per year. The sex ratio did not significantly vary over the period studied (p = 0.4 Cochran–Armitage trend test).
The median age of the patients was 60.1 years (51.1–73.0) (n = 28,249). It was significantly different between males and females, respectively 57.9 (50.0–68.3) years vs. 72.9 (58.3–82.2) years (p = 0.0004) and varied significantly over the course of the study period. The median age of males significantly increased from 57.6 years (50.1–70.0) in 2002 to 58.1 years (50.5–67.8) in 2014 (p = 0.0044 Cochran-Armitage trend test) (Figure 2). The median age of females significantly decreased from 73.7 (57.9–81.8) years in 2002 to 69.6 years (57.0–82.4) in 2014 (p = 0.0006 Cochran–Armitage trend test) (Figure 2). The evolution is represented on the age pyramid in Figure 2. The median gap between the age of men and women decreased significantly, from 16.1 to 11.5 years (p = 0.0002 Cochran-Armitage trend test) (Figure 2).
Significant increase in males (blue circles), from 57.6 years (50.1–70.0) to 58.1 years (50.5–67.8); Cochran-Armitage trend test: p = 0.0044. Significant decrease in females (red diamonds), from 73.7 years (57.9–81.8) to 69.6 years (57.0–82.4); Cochran–Armitage trend test: p = 0.0006.
Distribution between males and females was significantly different in 2002 and 2014 (p < 0.0001, Kolmogorov–Smirnov test). Distribution by quinquennial age was not significantly different between 2002 and 2014 for both females (p = 0.07, Kolmogorov–Smirnov test) and males (p = 0.15, Kolmogorov–Smirnov test) (Figure 3).
The prevalence of all risk factors differed significantly according to gender (Table 1). In addition, a significant variation in the prevalence of risk factors was observed between 2006 and 2014 with respect to family history of coronary artery disease, excess weight, dyslipidemia and (the) absence of a risk factor (Figure 4). For males, prevalence of excess weight, family history of coronary artery disease, smoking, dyslipidemia decreased significantly and that of hypertension increased significantly. The rate of men without past history (i.e., without any of the systematically recorded risk factors) increased significantly from 6 to 7% (p = 0.03). For women, only the prevalence of family history of coronary artery disease decreased significantly (Figure 3). The rate of women without past history of risk factors increased significantly from 9 to 12% (p = 0.02). Details of the evolution over the studied period are presented in annexe 1.
The total number of patients who died was 1134 (5.1%). In-hospital mortality rate was significantly higher in females than in males: 485 (8.4%) vs. 851 (4.1%); p < 0.0001. In-hospital mortality rate significantly decreased during the study period, in the global population (p < 0.0001 Cochran–Armitage trend test) as well as and in males (p = 0.008) and females (p = 0.02) (Figure 5).

4. Discussion

The age of myocardial infarction occurrence significantly decreased in females (74–70 years) whereas it increased significantly, but to a lesser extent in males (from less than 58 years of age to more than 58). The median yearly age difference between males and females decreased dramatically by one third. For males, this evolution can be explained by a decrease in the prevalence of all cardiovascular risk factors (with the exception of arterial hypertension). In contrast, for females, we did not find any significant variation in the prevalence of any single risk factor to explain this evolution. This increase occurred in the context of a one-third increase in patients without risk factors. This observation has a major impact on prevention policies.
An overall trend towards a reduced incidence of acute myocardial infarction has been found in many international studies. Nevertheless, this trend, particularly in France, seemed to be associated with a paradoxical increase in the prevalence of acute myocardial infarction in women under 65 years. The opposite trend was clearly observed in males over the course of this 13-year analysis. A difference of 9 years between median of males and females suffering acute myocardial infarction has been found in an international study. This difference was 7 years in Europe, whereas it was 15 years at the same period in our study [11]. The increase in the prevalence of smoking and, more generally, in the prevalence of risk factors was the first proposed explanation potentially accounting for the trend observed in women. Smoking seemed all the more plausible as it is a major risk factor of acute myocardial infarction onset particularly in young patients. However, this hypothesis was based on weak epidemiological data. The evolution of the prevalence of smoking has been estimated by surveys. Our results clearly show that not only has the prevalence of smoking not increased in women suffering acute myocardial infarction, but that acute myocardial infarction has occurred in an increased number of patients without risk factors. However, the number of patients without any established risk factors remains low. This observation has two major consequences: (1) it suggests another explanation for this evolution and (2) it impacts prevention policies.
The impact of gender on the occurrence, the management and the prognosis of acute coronary syndrome is well known [12]. Overall, females are treated later, benefit less from coronary reperfusion and have higher mortality than males [13,14]. This excess mortality involves multiple confounding factors such as age, prevalence of diabetes or treatment strategies. Multivariate analyses have shown that being a woman remains an independent factor accounting for the lack of reperfusion decisions and excess mortality [15,16]. Such a difference is found even in young women [17].
One of the proposed explanations is the hormonal factor. Even though estrogen protects women against cardiovascular events [18], it may also make them more vulnerable to an acute ischemic event [19]. However, that hormones influence the risk of myocardial infarction in female is debated [20]. In addition, the mechanisms of the acute event could differ, especially in patients without cardiovascular risk factors [21]. Thus, although coronal plaque rupture predominates in males, plaque erosion and microemboli production appear to be more common in females [22]. In contrast, coronary dissection and parietal hematoma are more common in females. This could explain up to 10% of STEMI in females before the age of 50 [23]. Smoking is usually the sole risk factor in young females with acute myocardial infarction [9,24]. Therefore, the relation between smoking, coronary dissection and parietal hematoma should be investigated. Arterial aging could also be different in females [25].
STEMI can occur in patients with few "traditional" cardiovascular risk factors, which is in keeping with our findings. The formation of an intra-mural hematoma from an acquired parietal lesion or not, is, in this case, the basic mechanism of coronary occlusion. The treatment of acute myocardial infarction is currently the same in men and women. In cases of dissection or coronary hematoma, the strategy based on antithrombotic and platelet energetics treatment is no longer suitable. A better knowledge of these physiopathological differences could result in the development of different therapeutic strategies. This could, in turn, influence prevention policies.
Primary (and secondary) prevention of cardiovascular (and neurovascular) events are based on an optimal consideration of risk factors. The marked increase in the occurrence of myocardial infarction without risk factors in increasingly younger women is, in this respect, problematic. A better knowledge of the physiopathological mechanisms of the acute coronary syndrome in women is essential. Consideration of other risk factors can be crucial. Authors recently concluded that the higher risk of myocardial infarction in females could not be explained by established risk factors [20]. Other risk factors such as psychosocial factors, sedentary lifestyle or weather could affect males and females differently [11,26]. In contrast, protective factors such as fruit and vegetable consumption or physical activity are not routinely recorded [11]. Moreover, interactions between risk and protective factors and gender is complex [27]. Special attention should be paid to the preventive education of patients, especially those who are known to carry established risk factors. These patients should quickly enter the care system in order to avoid any further increase in the risk of delayed treatment as well as morbidity and mortality. Dedicated guidelines and education campaigns on the risks specific to women have been developed [28,29]. Physicians should be carefully when managing chest pain in young females with only low or even no risk factors [27]. Reducing sex-based differences in management and outcome of STEMI patients is a modern challenge [30,31].

5. Limitations

The first limitation to this work is the lack of recording of risk factors during the first six years of the study period. While this limitation may complicate the analysis, it does not alter the main result of the study. The second limitation concerns the exclusive inclusion of patients who were managed in a prehospital setting by the SAMU-Center 15 system. This represents a rate of approximately 50% of the patients in the region. Variations between these two populations of patients cannot be excluded. Nevertheless, in this analysis, the inclusion of patients secondarily transferred from one institution to another limits the risk of selection bias. How our results can be extrapolated to all the patients with acute coronary syndrome is uncertain. Only patients with ST segment elevation myocardial infarction have been included in the study, while patients with any other feature of acute coronary syndromes are not, currently, included in our registry. However, to the best of our knowledge, STEMI and other acute coronary syndromes are usually considered to be related to identical risk factors. Females have worse outcomes in case of non-STEMI too [32]. Investigations focused on the evolution of risk factors in non-STEMI acute coronary syndrome would be of interest to improve prevention campaigns. Finally, the extrapolation of our results to other regions or even to other countries will need to be confirmed by specific analyses.

6. Conclusions

The age of onset of myocardial infarction has decreased by four years in females without any significant variation in the prevalence of risk factors to account for this. In particular, the role of smoking, which is readily incriminated, was not substantiated here. Identifying specific risk factors is crucial to optimizing prevention policies.

Author Contributions

Conceptualization, A.L., J.-M.J. and F.L.; Data curation, A.L. and S.B.; Formal analysis, A.L.; Funding acquisition, F.D.; Investigation, S.T., T.B., L.L., V.P., B.S., G.L.B., A.A., J.-M.J. and Y.L.; Methodology, A.L. and F.L.; Project administration, A.L., H.B., S.B., S.T., T.B., L.L., V.P., B.S., F.D., G.L.B., A.A. and Y.L.; Resources, S.B.; Software, S.B.; Supervision, Y.L.; Writing—original draft, F.L.; Writing—Review & editing, H.B., L.W. and Y.L.

Funding

This research received no external funding.

Acknowledgments

F.L.: Astra-Zeneca, Bayer, BMS, Boehringer-Ingelheim, Daiichy-Sankyo, Lilly, Medtronic, Merck-Serono, Mundipharma, Novartis, Teleflex; Investigators: CH d’Arpajon (Arpajon): Nabil Bensalem, Michel Rivoal, Gilles Touitou, Lisa Rodriguez; CH d’Orsay (Orsay): Laurent Alayrac, Roland Hellio, Carlos Nunes; CH de Coulommiers (Coulommiers): Frédéric Compagnon, Samir Toumani; CH de Fontainebleau (Fontainebleau): Christophe Fossay, Phillipe Grippon; CH de Gonesse (Gonesse): Caroline Birlouez, Jean-Luc Sebbah, Dominique Thevenin; CH de Juvisy sur Orge (Juvisy sur Orge): Gaële Aubert, François Clavié, Ducommun, Bruno Faggianelli, Sophie Schvahn; CH de Longjumeau (Longjumeau): Jean-Michel Coudray, Alain Hautefeuille, Pierre Parpet, Emmanuel Rousseau, Thrung-Hung Ta; CH de Marne la Vallée (Jossigny): Géraud Mathieu, Nicolas Porcher, Olivier Stibbe; CH de Meaux (Meaux): Françoise Bouvet, Franck Goes, Véronique Limoges, Hervé Thomas; CH de Melun (Melun): François Dolveck, Jean-Yves Letarnec, Virginie Pires, Laurent Rebillard, Karim Tazarourte; CH de Montereau (Montereau): Hassane Amokrane, François Cadot; CH de Nemours (Nemours): Dr Coletta, Eric Demiere; CH de Pontoise (Pontoise): Louenas Boukacem, François Dupas, Marc Giroud, Agnès Ricard-Hibon; CH de Provins (Provins): Sylvia Cineux, Laurent D’Araujo, Patricia Roy, Frédéric Tarlier; CH de Rambouillet (Rambouillet): Caroline Chevrier, Joël Clero; CH de Versailles (Le Chesnay): Françoise Boutot, Yves Lambert, Julian Moro, Olivier Richard, Wilfrid Sammut; CH d’Etampes (Etampes): Bouhadjar Benaicha, Céline Gaffinel, Olwenn Jeufraux, Kevin Legendre, Patricia Nguyen, Jean-Marc Pone; CH du Dr Delafontaine (Saint-Denis): Brigitte Hennequin; CH François Quesnay (Mantes la Jolie): Albert Goldman, Stéphane Hazan, Laure Hoffman, Vincent Pasquereau, Pierre-Marc Viso; CH Robert Ballanger (Aulnay sous Bois): Didier Biens, Pierre Charestan, Pierre Mézard, Valérie Raphaël; CH Simone Veil (Eaubonne): François Belotte, Indragitha Lefevre, Valérie Monfroy, Fabrice Pouradier; CH Sud Francilien (Corbeil-Essonnes): Nicolas Briole, Georges-Antoine Capitani, Jean-Philippe Desclefs, François-Xavier Laborne, Claude Pouges, Nathalie Roignant, Benoît Simon; CH Victor Dupouy (Argenteuil): Chantal Cuvier, Frédéric Munoz; CHI de Villeneuve Saint Georges (Villeneuve Saint Georges): Harold Auger, Corinne Bergeron, Eric Meinadier, Paulin Tshisumbule; CHI des Portes de l’Oise (Beaumont): Thierry Binda, Dominique Le Foll-Llanas, Jean-Louis Rakotonirina; CHI Le Raincy-Montfermeil (Montfermeil): Arielle Beruben, Patrice Cavagna, Julie Kergueno; CHI Poissy-Saint Germain en Laye (Poissy): Renaud Getti, Martine Lefevre, Cédric Ramaut, Ramon Ruiz Almenar; Hôpital Avicenne (APHP) (Bobigny): Sarah Tepper, Frédéric Adnet, Frédéric Lapostolle; Hôpital Beaujon (APHP) (Clichy): Marie-Laure Devaud, François-Xavier Duchateau, Jean Mantz; Hôpital Henri Mondor (APHP) (Créteil): Aurore Debit, Catherine Bertrand, Thevy Boche, Laurence Goldstein, Line Jacob, Agnieszka Ladka, Candice Penet, Jean Marty; Hôpital Hôtel Dieu (APHP) (Paris): Thiziri Benmayouf, Stéphane Boizat, Amandine Bourgeois, Benjamin Dahan, Paul Eche, Gérard Kierzek, Guillaume Der Sahakian, Jean-Louis Pourriat; Hôpital Lariboisière (APHP) (Paris): Agathe Chaplain, Papa Gueye, Miguel Pereira, Didier Payen; Hôpital Necker (APHP) (Paris), Murielle Jaffry, Romain Corrocher, Lionel Lamhaut, Pierre Carli; Hôpital Pitié-Salpétrière (APHP) (Paris): Guillaume Boon, Mathieu Delay, Patrick Ecollan, Julie Kergueno; Hôpital Raymond Poincaré (APHP) (Garches): Michel Baer, Séverine Cahun-Giraud, Sybille Goddet, Gaëlle Le Bail; Hôpital Saint-Antoine (APHP) (Paris): Dr Bourquard, Patrick Brard; BSPP G1 Montreuil (Montreuil): Alain Courtiol, Yann-Laurent Violin; BSPP G2 Vitry (Vitry): Alexandre Allonneau, Isabelle Klein, Geoffroy Thirion; BSPP G3 Plessis-Clamart (Clamart): Jonathan Gonzva, Julien Charton, Olivier Yavari-Sartakhti; BSPP Service Médical d’Urgence (Paris): Michel Bignand, Daniel Jost, Jean-Pierre Tourtier.

Conflicts of Interest

The authors declare no conflict of interest.

References

  1. Gerber, Y.; Weston, S.A.; Jiang, R.; Roger, V.L. The changing epidemiology of myocardial infarction in Olmsted County, Minnesota, 1995–2012. Am. J. Med. 2015, 128, 144–151. [Google Scholar] [CrossRef] [PubMed]
  2. Dégano, I.R.; Salomaa, V.; Veronesi, G.; Ferriéres, J.; Kirchberger, I.; Laks, T.; Havulinna, A.S.; Ruidavets, J.B.; Ferrario, M.M.; Meisinger, C.; et al. Twenty-five-year trends in myocardial infarction attack and mortality rates, and case-fatality, in six European populations. Heart 2015, 101, 1413–1421. [Google Scholar] [CrossRef] [PubMed]
  3. Puymirat, E.; Simon, T.; Steg, P.G.; Schiele, F.; Guéret, P.; Blanchard, D.; Khalife, K.; Goldstein, P.; Cattan, S.; Vaur, L.; et al. Association of changes in clinical characteristics and management with improvement in survival among patients with ST-elevation myocardial infarction. JAMA 2012, 308, 998–1006. [Google Scholar] [CrossRef] [PubMed]
  4. Chockalingam, A.; Campbell, N.R.; Fodor, J.G. Worldwide Epidemic of Hypertension. Available online: http://www.ncbi.nlm.nih.gov/pmc/articles/PMC2560860/ (accessed on 28 June 2017).
  5. Galka, M. How the World Got Fat: A Visualisation of Global Obesity over 40 Years. Available online: http://www.theguardian.com/global-development-professionals-network/2017/jan/03/using-data-visualisations-to-help-explain-the-global-obesity-explosion (accessed on 28 June 2017).
  6. Global Report on Diabetes. Available online: http://www.who.int/diabetes/global-report/en/ (accessed on 28 June 2017).
  7. Gupta, A.; Wang, Y.; Spertus, J.A.; Geda, M.; Lorenze, N.; Nkonde-Price, C.; D’Onofrio, G.; Lichtman, J.H.; Krumholz, H.M. Trends in acute myocardial infarction in young patients and differences by sex and race, 2001 to 2010. J. Am. Coll. Cardiol. 2014, 64, 337–345. [Google Scholar] [CrossRef] [PubMed]
  8. Guignard, R.; Beck, F.; Wilquin, J.-L.; Andler, R.; Nguyen-Thanh, V.; Richard, J.-B.; Arwidson, P. La consommation de tabac en France et son évolution: Résultats du Baromètre santé 2014. BEH. 2015, 17–18, 281–288. (In French) [Google Scholar]
  9. Marques-Vidal, P.; Cambou, J.P.; Ferrières, J.; Thomas, D.; Grenier, O.; Cantet, C.; Danchin, N.; Prevenir, E. Distribution and treatment of cardiovascular risk factors in coronary patients: The prevenir Study. Arch. Mal. Coeur. Vaiss. 2001, 94, 673–680. [Google Scholar] [PubMed]
  10. Available online: http://www.bmj.com/about-bmj/resources-readers/publications/statistics-square-one/11-correlation-and-regression (accessed on 14 January 2018).
  11. Yusuf, S.; Hawken, S.; Ounpuu, S.; Dans, T.; Avezum, A.; Lanas, F.; McQueen, M.; Budaj, A.; Pais, P.; Varigos, J.; et al. Effect of potentially modifiable risk factors associated with myocardial infarction in 52 countries (the INTERHEART study): Case-control study. Lancet Lond. Engl. 2004, 364, 937–952. [Google Scholar] [CrossRef]
  12. Vaccarino, V.; Parsons, L.; Every, N.R.; Barron, H.V.; Krumholz, H.M. Sex-based differences in early mortality after myocardial infarction. N. Engl. J. Med. 1999, 341, 217–225. [Google Scholar] [CrossRef]
  13. Benamer, H.; Tafflet, M.; Bataille, S.; Escolano, S.; Livarek, B.; Fourchard, V.; Caussin, C.; Teiger, E.; Garot, P.; Lambert, Y.; et al. Female gender is an independent predictor of in-hospital mortality after STEMI in the era of primary PCI: Insights from the greater Paris area PCI Registry. EuroIntervention 2011, 6, 1073–1079. [Google Scholar] [CrossRef]
  14. Sederholm Lawesson, S.; Isaksson, R.-M.; Thylén, I.; Ericsson, M.; Ängerud, K.; Swahn, E.; SymTime Study Group. Gender differences in symptom presentation of ST-elevation myocardial infarction—An observational multicenter survey study. Int. J. Cardiol. 2018, 264, 7–11. [Google Scholar] [CrossRef]
  15. Alabas, O.A.; Gale, C.P.; Hall, M.; Rutherford, M.J.; Szummer, K.; Lawesson, S.S.; Alfredsson, J.; Lindahl, B.; Jernberg, T. Sex differences in treatments, relative survival, and excess mortality following acute myocardial infarction: National cohort study using the SWEDEHEART registry. J. Am. Heart Assoc. 2017, 6. [Google Scholar] [CrossRef] [PubMed]
  16. Potts, J.; Sirker, A.; Martinez, S.C.; Gulati, M.; Alasnag, M.; Rashid, M.; Kwok, C.S.; Ensor, J.; Burke, D.L.; Riley, R.D.; et al. Persistent sex disparities in clinical outcomes with percutaneous coronary intervention: Insights from 6.6 million PCI procedures in the United States. PLoS ONE 2018. [Google Scholar] [CrossRef] [PubMed]
  17. Cenko, E.; Yoon, J.; Kedev, S.; Stankovic, G.; Vasiljevic, Z.; Krljanac, G.; Kalpak, O.; Ricci, B.; Milicic, D.; Manfrini, O.; et al. Sex differences in outcomes after STEMI: Effect modification by treatment strategy and age. JAMA Intern. Med. 2018, 178, 632–639. [Google Scholar] [CrossRef] [PubMed]
  18. Mendelsohn, M.E.; Karas, R.H. The protective effects of estrogen on the cardiovascular system. N. Engl. J. Med. 1999, 340, 1801–1811. [Google Scholar] [CrossRef] [PubMed]
  19. Johansson, S.; Bergstrand, R.; Ulvenstam, G.; Vedin, A.; Wilhelmsson, C.; Wedel, H.; Wilhelmsen, L.; Aberg, A. Sex differences in preinfarction characteristics and longterm survival among patients with myocardial infarction. Am. J. Epidemiol. 1984, 119, 610–623. [Google Scholar] [CrossRef] [PubMed]
  20. Albrektsen, G.; Heuch, I.; Løchen, M.-L.; Thelle, D.S.; Wilsgaard, T.; Njølstad, I.; Bønaa, K.H. Lifelong gender gap in risk of incident myocardial infarction: The Tromsø study. JAMA Intern. Med. 2016, 176, 1673–1679. [Google Scholar] [CrossRef] [PubMed]
  21. Johannes, J.; Bairey Merz, C.N. Is cardiovascular disease in women inevitable?: Preparing for menopause and beyond. Cardiol. Rev. 2011, 19, 76–80. [Google Scholar] [CrossRef] [PubMed]
  22. Arbustini, E.; Dal Bello, B.; Morbini, P.; Burke, A.P.; Bocciarelli, M.; Specchia, G.; Virmanic, R. Plaque erosion is a major substrate for coronary thrombosis in acute myocardial infarction. Heart Br. Card. Soc. 1999, 82, 269–272. [Google Scholar] [CrossRef] [Green Version]
  23. Vanzetto, G.; Berger-Coz, E.; Barone-Rochette, G.; Chavanon, O.; Bouvaist, H.; Hacini, R.; Blin, D.; Machecourt, J. Prevalence, therapeutic management and medium-term prognosis of spontaneous coronary artery dissection: Results from a database of 11,605 patients. Eur. J. Cardiothorac. Surg. 2009, 35, 250–254. [Google Scholar] [CrossRef]
  24. Gleerup, H.B.; Dahm, C.C.; Thim, T.; Jensen, S.E.; Jensen, L.O.; Kristensen, S.D.; Bøtker, H.E.; Maeng, M. Smoking is the dominating modifiable risk factor in younger patients with STEMI. Eur. Heart J. Acute Cardiovasc. Care 2018. [Google Scholar] [CrossRef]
  25. Coutinho, T. Arterial stiffness and its clinical implications in women. Can. J. Cardiol. 2014, 30, 756–764. [Google Scholar] [CrossRef] [PubMed]
  26. Gebhard, C.; Gebhard, C.E.; Stähli, B.E.; Maafi, F.; Bertrand, M.-J.; Wildi, K.; Fortier, A.; Galvan Onandia, Z.; Toma, A.; Zhang, Z.W.; et al. Weather and risk of ST-elevation myocardial infarction revisited: Impact on young women. PLoS ONE 2018, 13. [Google Scholar] [CrossRef] [PubMed]
  27. Pedersen, L.R.; Frestad, D.; Michelsen, M.M.; Mygind, N.D.; Rasmusen, H.; Suhrs, H.E.; Eva, P. Risk factors for myocardial infarction in women and men: A review of the current literature. Curr. Pharm. Des. 2016, 22, 3835–3852. [Google Scholar] [CrossRef] [PubMed]
  28. Reimold, S.C.; Hill, J.A. inaugural go red for women issue. Circulation 2017, 135, 493–494. [Google Scholar] [CrossRef] [PubMed]
  29. Mehta, L.S.; Beckie, T.M.; DeVon, H.A.; Grines, C.L.; Krumholz, H.M.; Johnson, M.N.; Lindley, K.J.; Vaccarino, V.; Wang, T.Y.; Watson, K.E.; et al. Acute myocardial infarction in women: A scientific statement from the american heart association. Circulation 2016, 133, 916–947. [Google Scholar] [CrossRef] [PubMed]
  30. Huded, C.P.; Johnson, M.; Kravitz, K.; Menon, V.; Abdallah, M.; Gullett, T.C.; Hantz, S.; Ellis, S.G.; Podolsky, S.R.; Meldon, S.W.; et al. 4-Step protocol for disparities in STEMI care and outcomes in women. J. Am. Coll. Cardiol. 2018, 71, 2122–2132. [Google Scholar] [CrossRef] [PubMed]
  31. Abbott, J.D.; Curtis, J.P. More than one way to close the gender gap. J. Am. Coll. Cardiol. 2018, 71, 2133–2135. [Google Scholar] [CrossRef] [PubMed]
  32. Langabeer, J.R.; Champagne-Langabeer, T.; Fowler, R.; Henry, T. Gender-based outcome differences for emergency department presentation ofnon-STEMI acute coronary syndrome. Am. J. Emerg. Med. 2018. [Google Scholar] [CrossRef]
Jcm 07 00509 g001 550
Figure 1. Strengthening the reporting of observational studies in epidemiology (STROBE) diagram of exclusions of cases from the Greater Paris area E-MUST registry.
Figure 1. Strengthening the reporting of observational studies in epidemiology (STROBE) diagram of exclusions of cases from the Greater Paris area E-MUST registry.
Jcm 07 00509 g001
Jcm 07 00509 g002 550
Figure 2. Evolution of the median age of STEMI patients by gender from 2002 to 2014 (n = 28,249). r, regression correlation coefficient.
Figure 2. Evolution of the median age of STEMI patients by gender from 2002 to 2014 (n = 28,249). r, regression correlation coefficient.
Jcm 07 00509 g002
Jcm 07 00509 g003 550
Figure 3. Comparison of the age pyramid of ST-elevation myocardial infarction (STEMI) patients by gender. (A) Years 2002 (n = 2205); (B) Year 2014 (n = 2349); (C) Years 2002 and Year 2014.
Figure 3. Comparison of the age pyramid of ST-elevation myocardial infarction (STEMI) patients by gender. (A) Years 2002 (n = 2205); (B) Year 2014 (n = 2349); (C) Years 2002 and Year 2014.
Jcm 07 00509 g003
Jcm 07 00509 g004 550
Figure 4. Evolution of the prevalence of risk factors, in the general population, and in males and females, from 2006 to 2014 (n = 19,684).
Figure 4. Evolution of the prevalence of risk factors, in the general population, and in males and females, from 2006 to 2014 (n = 19,684).
Jcm 07 00509 g004
Jcm 07 00509 g005 550
Figure 5. Evolution of the prevalence of risk factors, in the general population, and in males and females, from 2006 to 2014 (n = 20,758).
Figure 5. Evolution of the prevalence of risk factors, in the general population, and in males and females, from 2006 to 2014 (n = 20,758).
Jcm 07 00509 g005
Table
Table 1. Comparison of the prevalence of risk factors according to gender (n = 19,684).
Table 1. Comparison of the prevalence of risk factors according to gender (n = 19,684).
nMenWomenp-Value (khi2 Test)
Personal coronary history19,0772772 (19%)709 (17%)0.0015
Family coronary artery disease19,0762664 (18%)681 (16%)0.0019
Smoking19,0188686 (59%)1406 (33%)<0.0001
Diabetes19,0762309 (16%)777 (18%)<0.0001
Hypertension19,0785507 (37%)2306 (54%)<0.0001
Dyslipidemia19,0795242 (35%)1404 (33%)0.0021
Excess weight19,0823633 (25%)982 (23%)0.0388
Absence of risk factor19,0761054 (7%)413 (10%)<0.0001

Share and Cite

MDPI and ACS Style

Loyeau, A.; Benamer, H.; Bataille, S.; Tepper, S.; Boche, T.; Lamhaut, L.; Pirès, V.; Simon, B.; Dupas, F.; Weisslinger, L.; et al. Evolution of ST-Elevation Acute Myocardial Infarction Prevalence by Gender Assessed Age Pyramid Analysis—The Piramyd Study. J. Clin. Med. 2018, 7, 509. https://doi.org/10.3390/jcm7120509

AMA Style

Loyeau A, Benamer H, Bataille S, Tepper S, Boche T, Lamhaut L, Pirès V, Simon B, Dupas F, Weisslinger L, et al. Evolution of ST-Elevation Acute Myocardial Infarction Prevalence by Gender Assessed Age Pyramid Analysis—The Piramyd Study. Journal of Clinical Medicine. 2018; 7(12):509. https://doi.org/10.3390/jcm7120509

Chicago/Turabian Style

Loyeau, Aurélie, Hakim Benamer, Sophie Bataille, Sarah Tepper, Thévy Boche, Lionel Lamhaut, Virginie Pirès, Benoit Simon, François Dupas, Lisa Weisslinger, and et al. 2018. "Evolution of ST-Elevation Acute Myocardial Infarction Prevalence by Gender Assessed Age Pyramid Analysis—The Piramyd Study" Journal of Clinical Medicine 7, no. 12: 509. https://doi.org/10.3390/jcm7120509

Note that from the first issue of 2016, this journal uses article numbers instead of page numbers. See further details here.

Article Metrics

Back to TopTop